University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Reminder Focused Positive Psychiatry in Adolescents With ADHD and PTSD

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorder
Attention Deficit Hyperactivity Disorder

Interventions: Behavioral: TFCBT
Behavioral: RFPP

First Posted Date: 2020-04-07

Last Posted Date: 2020-04-08

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 11

Registration Number: NCT04336072

Locations: 🇺🇸
UCLA Kern, Los Angeles, California, United States

Testing Mediators and Moderators of a Fotonovela for Depression to Promote Help-seeking Behavior

Not Applicable

Conditions: Mental Health Literacy

Interventions: Behavioral: Fotonovela
Behavioral: Control

First Posted Date: 2020-03-24

Last Posted Date: 2020-03-25

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 182

Registration Number: NCT04319458

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States

Revefenacin in Acute Respiratory Insufficiency in COPD

Phase 2

Recruiting

Conditions: COPD
Acute Respiratory Failure

Interventions: Drug: Revefenacin Inhalation Solution [Yupelri]
Drug: Ipratropium Bromide

First Posted Date: 2020-03-19

Last Posted Date: 2024-12-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 21

Registration Number: NCT04315558

Locations: 🇺🇸
Ronald Reagan Medical Center at UCLA, Los Angeles, California, United States
🇺🇸
Santa Monica UCLA, Santa Monica, California, United States

Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents

Not Applicable

Active, not recruiting

Conditions: Ascites
Hypertension, Portal

Interventions: Device: Gore® Viatorr® Endoprosthesis with controlled expansion
Procedure: Large Volume Paracentesis with albumin infusion

First Posted Date: 2020-03-19

Last Posted Date: 2025-05-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 68

Registration Number: NCT04315571

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States

Development of a Selective ALDH2 Inhibitor to Treat AUD

Phase 2

Withdrawn

Conditions: Alcohol Use Disorder

Interventions: Drug: ANS-6637 Low Dose
Drug: ANS-6637 High Dose
Drug: Matched Placebo

First Posted Date: 2020-03-17

Last Posted Date: 2021-05-25

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT04311294

Locations: 🇺🇸
UCLA Addictions Lab, Los Angeles, California, United States

FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD

Withdrawn

Conditions: Suspected Chronic Traumatic Encephalopathy (CTE) or Traumatic Encephalopathy Syndrome (TES)
Suspected Alzheimer's Disease (AD)

Interventions: Biological: [F-18]FDDNP-PET

First Posted Date: 2020-03-17

Last Posted Date: 2021-05-06

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT04311281

An Inflammatory Challenge Using Endotoxin

Phase 2

Completed

Conditions: Depressed Mood
Inflammatory Response
Alcohol Use Disorder
Craving

Interventions: Drug: Placebo
Biological: Endotoxin

First Posted Date: 2020-03-17

Last Posted Date: 2025-05-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 20

Registration Number: NCT04310423

Locations: 🇺🇸
UCLA Addictions Laboratory, Los Angeles, California, United States

Digital Behavioral Therapy for Sleep Problems

Not Applicable

Terminated

Conditions: Insomnia

Interventions: Behavioral: Digital cognitive-behavioral therapy for insomnia (dCBTI)
Behavioral: Sleep hygiene education (SHE)

First Posted Date: 2020-03-16

Last Posted Date: 2024-05-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 24

Registration Number: NCT04308499

Locations: 🇺🇸
UCLA Cousins Center for Psychoneuroimmunology, Los Angeles, California, United States

Theophylline for Depression Study

Early Phase 1

Withdrawn

Conditions: Depression

Interventions: Drug: Theophylline ER
Other: PO placebo
Other: IV placebo
Biological: Lipopolysaccharide (LPS)

First Posted Date: 2020-03-16

Last Posted Date: 2021-11-05

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT04309877

Locations: 🇺🇸
UCLA Cousins Center for Psychoneuroimmunology, Los Angeles, California, United States

Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure

Not Applicable

Terminated

Conditions: Anterior Blepharitis

Interventions: Device: Microblepharoexfoliative procedure with BlephEx™
Procedure: Eyelid cleansing with eyelid wipes (Optase)
Procedure: Daily eyelid cleansing with eyelid wipes (Optase)

First Posted Date: 2020-03-02

Last Posted Date: 2021-02-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 2

Registration Number: NCT04290455

Locations: 🇺🇸
Stein Eye Institute, UCLA, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy